Department of Psychiatry, Carver College of Medicine at the University of Iowa, Iowa City, IA, USA.
Department of Neurology, Carver College of Medicine at the University of Iowa, Iowa City, IA, USA.
Ann Neurol. 2024 Nov;96(5):1006-1019. doi: 10.1002/ana.27046. Epub 2024 Aug 8.
Huntington's disease (HD) is a neurodegenerative disease caused by a triplet repeat expansion within the gene huntingtin (HTT). Antagonistic pleiotropy is a theory of aging that posits that some genes, facilitating individual fitness early in life through adaptive evolutionary changes, also augment detrimental aging-related processes. Antagonistic pleiotropy theory may explain a positive evolutionary pressure toward functionally advantageous brain development that is vulnerable to rapid degeneration. The current study investigated antagonistic pleiotropy in HD using a years-to-onset paradigm in a unique sample of children and young adults at risk for HD.
Cognitive, behavioral, motor, and brain structural measures from premanifest gene-expanded (n = 79) and gene nonexpanded (n = 112) participants (6-21 years) in the Kids-HD study were examined. All measures in the gene-expanded group were modeled using a mixed-effects regression approach to assess years-to-onset-based changes while controlling for normal growth. Simultaneously, structure-function associations were also examined.
Decades from motor onset, gene-expanded participants showed significantly better cognitive, behavioral, and motor scores versus gene nonexpanded controls, along with larger cerebral volumes and cortical features. After this initial peak, a prolonged deterioration was observed in both functional and structural measures. Far from onset, brain measures were positively correlated with functional measures, supporting the view that functional advantages were mediated by structural differences.
Mutant HTT may drive the development of a larger than normal brain that subserves superior early-life function. These findings support the antagonistic pleiotropy theory of HTT in HD, where this gene drives early advantage followed by accelerated aging processes. ANN NEUROL 2024;96:1006-1019.
亨廷顿病(HD)是一种神经退行性疾病,由亨廷顿基因(HTT)内的三核苷酸重复扩展引起。拮抗多效性是衰老的一种理论,该理论假设,一些基因通过适应性进化变化,在生命早期促进个体适应性,也会增加与衰老相关的有害过程。拮抗多效性理论可以解释有利于大脑功能的积极进化压力,而大脑功能容易迅速退化。本研究在亨廷顿病的发病前模型中,利用亨廷顿病高危儿童和年轻人的独特样本,研究了 HD 中的拮抗多效性。
在 Kids-HD 研究中,对 79 名有基因扩展(n=79)和 112 名无基因扩展(n=112)的前显型基因扩展参与者的认知、行为、运动和大脑结构测量值进行了研究。在基因扩展组中,所有测量值都采用混合效应回归方法进行建模,以评估基于发病前的变化,同时控制正常生长。同时,还检查了结构-功能关联。
在运动发病前几十年,基因扩展参与者的认知、行为和运动评分明显优于无基因扩展对照组,同时大脑体积和皮质特征也更大。在最初的高峰之后,功能和结构测量都出现了长时间的恶化。在发病很久以后,大脑测量值与功能测量值呈正相关,这支持了功能优势是由结构差异介导的观点。
突变 HTT 可能会促使大脑发育得比正常情况下更大,从而支持生命早期的功能更优越。这些发现支持了 HTT 在 HD 中的拮抗多效性理论,即该基因在早期优势之后,会加速衰老过程。ANN NEUROL 2024;96:1006-1019。